ストックスクリーナーアプリを入手
0.776
2.39%
-0.0142
アフターアワーズ：
.77
-0.006
-0.77%
前日終値:
$0.7902
開ける：
$0.7897
24時間の取引高:
375.57K
Relative Volume:
1.39
時価総額：
$43.54M
収益：
$3.10M
当期純損益:
$-97.43M
株価収益率:
-0.3495
EPS:
-2.22
ネットキャッシュフロー:
$-94.38M
1週間 パフォーマンス:
-23.63%
1か月 パフォーマンス:
-27.92%
6か月 パフォーマンス:
-64.78%
1年 パフォーマンス:
-59.62%
1日の値動き範囲:
$0.7663
$0.8169
1週間の範囲:
$0.75
$1.0125
52週間の値動き範囲:
$0.75
$6.30
Omega Therapeutics Inc Stock (OMGA) Company Profile
名前
Omega Therapeutics Inc
セクター
電話
(617) 949-4360
住所
140 FIRST STREET, SUITE 501, CAMBRIDGE
OMGA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| OMGA | 0.776 | 43.54M | 3.10M | -97.43M | -94.38M | -2.22 |
| VRTX | 450.37 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-12-08 | 開始されました | H.C. Wainwright | Buy |
| 2022-09-23 | 開始されました | Chardan Capital Markets | Buy |
Omega Therapeutics Inc (OMGA) 最新ニュース
Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates - MSN
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer – Company Announcement - Financial Times
Piper Sandler Lowers Omega Therapeutics (NASDAQ:OMGA) Price Target to $4.00 - Defense World
Omega Therapeutics Reports Third Quarter 2024 Results - TipRanks
Omega Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Omega Therapeutics stock target cut, keeps Overweight on clinical updates By Investing.com - Investing.com Canada
Shares of Flagship-founded biotech fall as CEO departs - The Business Journals
Omega Therapeutics (NASDAQ:OMGA) Downgraded to Market Perform Rating by Raymond James - MarketBeat
Piper Sandler Issues Pessimistic Forecast for Omega Therapeutics (NASDAQ:OMGA) Stock Price - MarketBeat
Omega Therapeutics Inc (OMGA) Quarterly 10-Q Report - Quartzy
Omega Therapeutics Names Kaan Certel as CEO - MarketWatch
Omega Therapeutics Announces Successful Completion of Phase - GlobeNewswire
Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results - The Manila Times
Omega Therapeutics, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner - Financial Times
Omega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9%Should You Sell? - MarketBeat
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last? - Yahoo Finance
Zura Bio (NASDAQ:ZURA) versus Omega Therapeutics (NASDAQ:OMGA) Critical Contrast - Defense World
Omega Therapeutics stock hits 52-week low at $0.94 By Investing.com - Investing.com Australia
Cubist Systematic Strategies LLC Grows Holdings in Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings - The Manila Times
Omega Therapeutics to Present Multiple Posters Highlighting - GlobeNewswire
Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - Financial Times
Omega Therapeutics stock hits 52-week low at $1.07 By Investing.com - Investing.com Australia
Omega Therapeutics stock hits 52-week low at $1.07 - Investing.com India
Omega Therapeutics Appoints New Director - Investing.com India
Omega Therapeutics Welcomes Robert Rosiello to Board - TipRanks
Omega Therapeutics Appoints New Director By Investing.com - Investing.com UK
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors – Company Announcement - Financial Times
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors - Quantisnow
A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore - Financial Times
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer - Financial Times
Omega Therapeutics stock hits 52-week low at $1.2 By Investing.com - Investing.com Canada
Omega Therapeutics stock hits 52-week low at $1.2 - Investing.com
Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry – Company AnnouncementFT.com - Financial Times
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications - ForexTV.com
Omega Therapeutics reports tumor inhibition in liver cancer models - Investing.com
Omega Therapeutics Announces Publication of Epigenomic - GlobeNewswire
RNA-Based Therapeutics Market to Grow by USD 1.27 Billion (2024-2028) Due to Increased Investment and Funding, AI Trends Impacting RevenueTechnavio - The Malaysian Reserve
RNA-Based Therapeutics Market To Grow By USD 1.27 Billion (2024-2028) Due To Increased Investment And Funding, AI Trends Impacting RevenueTechnavio - MENAFN.COM
Omega Therapeutics (NASDAQ:OMGA) Stock Price Up 0.8% - MarketBeat
Omega Therapeutics (NASDAQ:OMGA) Shares Up 0.8% - Defense World
Omega Therapeutics stock hits 52-week low at $1.29 amid downturn - Investing.com Australia
Omega Therapeutics Inc (OMGA) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
3.56%
大文字化:
|
ボリューム (24 時間):